Intermittent PTH(1-84) is osteoanabolic but not osteoangiogenic and relocates bone marrow blood vessels closer to bone-forming sites

Journal of Bone and Mineral Research

Volumn 26, Issue 11, 2011, Pages 2583-2596

  Prisby, Rhonda ^a   Guignandon, Alain ^b,c   Vanden Bossche, Arnaud ^b,c   Mac Way, Fabrice ^b,c,d   Linossier, Marie Thérèse ^b,c   Thomas, Mireille ^b,c   Laroche, Norbert ^b,c   Malaval, Luc ^b,c   Langer, Max ^b,e   Peter, Zoltz Andrei ^f   Peyrin, Françoise ^b,e,g   Vico, Laurence ^b   Lafage Proust, Marie Hélène ^b  

^a UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

^b UNIVERSITÉ JEAN MONNET   (France)

^c UNIVERSITÉ JEAN MONNET   (France)

^d LAVAL UNIVERSITY   (Canada)

^e UNIVERSITÉ LYON 1   (France)

^f UNIVERSITÉ PARIS OUEST NANTERRE LA DÉFENSE   (France)

^g EUROPEAN SYNCHROTRON RADIATION FACILITY   (France)

Author keywords

Angiogenesis; bone vessel quantitative imaging; Neuropilin; Parathyroid hormone; Rat

Indexed keywords

BEVACIZUMAB; MESSENGER RNA; NEUROPILIN 1; NEUROPILIN 2; RECOMBINANT PARATHYROID HORMONE; TETRACYCLINE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE ANGIOGENESIS; BONE BLOOD FLOW; BONE GROWTH; BONE MASS; BONE REMODELING; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; DRUG INTERMITTENT THERAPY; ELECTRON TOMOGRAPHY; HISTOLOGY; MALE; MICROENVIRONMENT; NONHUMAN; OSSIFICATION; PROTEIN EXPRESSION; RAT; SINGLE DRUG DOSE; SYNCHROTRON RADIATION; TRABECULAR BONE; VASCULARIZATION;

ANABOLIC AGENTS; ANIMALS; ANTIBODIES; BLOOD VESSELS; BONE AND BONES; BONE MARROW; BONE REMODELING; GENE EXPRESSION REGULATION; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; ORGAN SIZE; OSTEOGENESIS; PARATHYROID HORMONE; RATS; RATS, WISTAR; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIBIA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80054969626     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.459     Document Type: Article

References (47)

1. Gerber H-P, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N,. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Medicine. 1999; 5: 623-628. (Pubitemid 29289424)
2. 18F-fluoride with positron emission tomography reveals damage- and time-dependent responses to fatigue loading in the rat ulna. Bone. 2006; 39: 229-236. (Pubitemid 44183796)
3. Matsuzaki H, Wohl GR, Novack DV, Lynch JA, Silva MJ,. Damaging fatigue loading stimulates increases in periosteal vascularity at sites of bone formation in the rat ulna. Calcif Tissue Int. 2007; 80: 391-399. (Pubitemid 46956769)
4. Parfitt A,. Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem. 1994; 55: 273-286. (Pubitemid 24218802)
5. Yao Z, Lafage-Proust MH, Plout J, Bloomfield S, Alexandre C, Vico L,. Increase of both angiogenesis and bone mass in response to exercise depends on VEGF. J Bone Miner Res. 2004; 19: 1471-1480. (Pubitemid 41094348)
6. Burkhardt R, Kettner G, Bohm W, Schmidmeier M, Schlag R, Frisch B, Mallmann B, Eisenmenger W, Gilg T,. Changes in trabecular bone, hematopoiesis and bone-marrow vessels in aplastic-anemia, primary osteoporosis, and old-age: a comparative histomorphometric study. Bone. 1987; 8: 157-164. (Pubitemid 17111858)
7. Prisby R, Ramsey MW, Behnke BJ, Dominguez JM, Donato AJ, Allen MR, Delp MD,. Aging reduces skeletal blood flow, endothelium-dependent vasodilation and nitric oxide bioavailability in rats. J. Bone Min Res. 2007; 22: 1280-1288. (Pubitemid 351339710)
8. Dominguez JM, Prisby RD, Muller-Delp JM, Allen MR, Delp MD,. Increased nitric oxide-mediated vasodilation of bone resistance arteries is associated with increased trabecular bone volume after endurance training in rats. Bone. 2010; 46: 813-819.
9. Henriksen K, Neutzsky-Wulff AV, Bonewald LF, Karsdal MA,. Local communication on and within bone controls bone remodeling. Bone. 2009; 44: 1026-1033.
10. Jüppner H, Abou-Samra AB, Freeman M, Kong XF, Schipani E, Richards J, Kolakowski LF Jr, Hock J, Potts JT Jr, Kronenberg HM,., et al. A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science. 1991; 254: 1024-1026. (Pubitemid 21917436)
11. Rashid G, Bernheim J, Green J, Benchetrit S,. Parathyroid hormone stimulates the endothelial nitric oxide synthase through protein kinase A and C pathways. Nephrol Dial Transplant. 2007; 10: 2831-2837. (Pubitemid 350093420)
12. Wang D, Yamazaki K, Nohtomi K, Shizume K, Ohsumi K, Shibuya M, Demura H, Sato K,. Increase of vascular endothelial growth factor mRNA expression by 1,25-dihydroxyvitamin D3 in human osteoblast-like cells. J Bone Miner Res. 1996; 11: 472-479.
13. Rashid G, Bernheim J, Green J, Benchetrit S,. Parathyroid hormone stimulates the endothelial expression of vascular endothelial growth factor. Eur J Clin Invest. 2008; 38: 798-803.
14. Eckardt H, Bundgaard KG, Christensen KS, Lind M, Hansen ES, Hvid I,. Effects of locally applied vascular endothelial growth factor (VEGF) and VEGF-inhibitor to the rabbit tibia during distraction osteogenesis. J Orthop Res. 2003; 21: 335-340. (Pubitemid 36322555)
15. Fogarty J, Muller-Delp JM, Delp MD, Mattox ML, Laughlin MH, Parker JL,. Exercise training enhances vasodilation responses to vascular endothelial growth factor in porcine coronary arterioles exposed to chronic coronary occlusion. Circulation. 2004; 109: 664-670. (Pubitemid 38198875)
16. Métais C, Li J, Li J, Simons M, Sellke FW,. Effects of coronary artery disease on expression and microvascular response to VEGF. Am J Physiol. 1998; 275: H1411-H1418.
17. Ashrafpour H, Huang N, Neligan PC, Forrest CR, Addison PD, Moses MA, Levine RH, Pang CY,. Vasodilator effect and mechanism of action of vascular endothelial growth factor in skin vasculature. Am J Physiol Heart Circ Physiol. 2004; 286: H946-H954. (Pubitemid 38248608)
18. Verhaar H, Lems WF,. PTH-analogs: comparable or different. Arch Gerontol Geriatr. 2009; 49: e130-e132.
19. Fei J, Peyrin F, Malaval L, Vico L, Lafage-Proust MH,. Imaging and quantitative assessment of long bone vascularization in the adult rat using microcomputed tomography. Anat Rec (Hoboken). 2010; 293: 215-224.
20. David V, Laroche N, Boudignon B, Lafage-Proust MH, Alexandre C, Ruegsegger P, Vico L,. Noninvasive in vivo monitoring of bone architecture alterations in hindlimb-unloaded female rats using novel three-dimensional microcomputed tomography. J Bone Miner Res. 2003; 18: 1622-1631. (Pubitemid 37022920)
21. Salomé M, Peyrin F, Cloetens P, Odet C, Laval-Jeantet AM, Baruchel J, Spanne P,. A synchrotron radiation microtomography system for the analysis of trabecular bone samples. Med Phys. 1999; 26: 2194-2204. (Pubitemid 29498675)
22. Labiche J-C, Maton O, Pascarelli S, Newton MA, Ferre GC, Curfs C, Vaughan G, Homs A, Carreiras DF,. Invited article: the fast readout low noise camera as a versatile X-ray detector for time resolved dispersive extended x-ray absorption fine structure and diffraction studies of dynamic problems in materials science, chemistry, and catalysis. Rev Sci Instrum. 2007; 78 (091301).
23. Langer M, Prisby R, Peter Z, Lafage-Proust M-H, Peyrin F,. Simultaneous 3D imaging of bone and vessel microstructure in a rat model. IEEE Transactions on Nuclear Science. 2011; 58: 139-145.
24. Chomcznski P, Mackey K,. Modification of the Tri Reagent procedure for isolation of RNA from polysaccharide- and proteoglycan-rich sources. Biotechniques. 1995; 19: 942-945.
25. Brookes M,. Sequelae of experimental partial ischaemia in long bones of the rabbit. J Anat. 1960; 94: 552-561.
26. De Saint-Georges L, Miller SC,. The micocirculation of bone and marrow in the diaphysis of the rat hemopoietic long bones. Anat Rec. 1992; 233: 169-177.
27. Parfitt A,. The mechanism of coupling: A role for the vasculature. Bone. 2000; 26: 319-323.
28. Cosman F, Greenspan S,. Parathyroid hormone treatment for osteoporosis. In:, Miller P, Papapoulos S, (eds.) Primer on the Metabolic Bone Disease and Disorders of Mineral Metabolism Washington DC, USA: American Society for Bone and Mineral Research; 2008. pp. 244-249.
29. Cochrane E, McCarthy ID,. Rapid effects of parathyroid hormone(1-34) and prostaglandin E2 on bone blood flow and strontium clearance in the rat in vivo. J Endocrinol. 1991; 131: 359-365.
30. Boelkins J, Mazurkiewicz M, Mazur PE, Mueller WJ,. Changes in blood flow to bones during the hypocalcemic and hypercalcemic phases of the response to parathyroid hormone. Endocrinology. 1976; 98: 403-412.
31. Shimoyama M, Ogino K, Uchida K, Furuse Y, Kinugasa Y, Taniguchim S, Igawa O, Hisatome I, Bilezikian JP, Shigemasa C,. Fragment-specific actions of parathyroid hormone in isolated perfused rat hearts. Calcif Tissue Int. 2001; 69: 88-93. (Pubitemid 32762910)
32. Towler D,. Vascular endothelial growth factor and osteogenic-angiogenic coupling. In:, Bilezikian J, Raisz LG, Martin TJ, (eds.) Principles of Bone Biology San Diego, CA, USA: Elsevier; 2008. pp. 1133-1144.
33. Deckers M, Karperien M, van der Bent C, Yamashita T, Papapoulos SE, Lowik CW,. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology. 2000; 141: 1667-1674. (Pubitemid 32274395)
34. Banerjee S, Mehta S, Haque I, Sengupta K, Dhar K, Kambhampati S, Van Veldhuizen PJ, Banerje SK,. VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis. Biochemistry. 2008; 47: 3345-3351. (Pubitemid 351399223)
35. Yang S, Yan S, Niu RL, Lin XK,. VEGF gene silencing by cytomegalovirus promoter driven shRNA expression vector results in vascular development defects in zebrafish. Genetika. 2009; 45: 1187-1193.
36. Harper J, Gerstenfeld LC, Klagsbrun M,. Neuropilin-1 expression in osteogenic cells: down-regulation during differentiation of osteoblasts into osteocytes. J Cell Biochem. 2001; 81: 82-92.
37. Gaur P, Bielenberg DR, Samuel S, Bose D, Zhou Y, Gray MJ, Dallas NA, Fan F, Xia L, Lu J, Ellis LM,. Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis. Clin Cancer Res. 2009; 15: 6763-6770.
38. Gomez C, Burt-Pichat B, Mallein-Gerin F, Merle B, Delmas PD, Skerry TM, Vico L, Malaval L, Chenu C,. Expression of Semaphorin-3A and its receptors in endochondral ossification: potential role in skeletal development and innervation. Dev Dyn. 2005; 234: 393-403. (Pubitemid 41369149)
39. Mayr-Wohlfart U, Waltenberger J, Hausser H, Kessler S, Gunther KP, Dehio C, Puhl W, Brenner RE,. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone. 2002; 30: 472-477. (Pubitemid 34204121)
40. Brookes M, Revell WJ,. Blood Supply of Bone: Scientific Aspects London: Springer-Verlag; 1998.
41. Huang M, Lu J, Ivanov Y, Sage AP, Tseng W, Demer LL, Tintut Y,. Hyperlipidemia impairs osteoanabolic effects of PTH. J Bone Miner Res. 2008; 23: 1672-1679.
42. Dempster D, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, PlavetiÄ K, Müller R, Bilezikian J, Lindsay R,. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res. 2001; 16: 1846-1853. (Pubitemid 32911491)
43. Rickard D, Wang FL, Rodriguez-Rojas AM, Wu Z, Trice WJ, Hoffman SJ, Votta B, Stroup GB, Kumar S, Nuttall ME,. Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells. Bone. 2006; 39: 1361-1372. (Pubitemid 44827918)
44. Kuznetsov S, Riminucci M, Ziran N, Tsutsui TW, Corsi A, Calvi L, Kronenberg HM, Schipani E, Robey PG, Bianco P,. The interplay of osteogenesis and hematopoiesis: expression of a constitutively active PTH/PTHrP receptor in osteogenic cells perturbs the establishment of hematopoiesis in bone and of skeletal stem cells in the bone marrow. J Cell Biol. 2004; 167: 1113-1122. (Pubitemid 40066626)
45. Pettway G, Schneider A, Koh AJ, Widjaja E, Morris MD, Meganck JA, Goldstein SA, McCauley LK,. Anabolic actions of PTH (1-34): use of a novel tissue engineering model to investigate temporal effects on bone. Bone. 2005; 36: 959-970. (Pubitemid 40797996)
46. Dobnig H, Turner RT,. Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology. 1995; 136: 3632-3638.
47. Friedl G, Turner RT, Evans GL, Dobnig H,. Intermittent parathyroid hormone (PTH) treatment and age-dependent effects on rat cancellous bone and mineral metabolism. J Orthop Res. 2007; 25: 1454-1464. (Pubitemid 350205593)